01 / AVAILABILITY
See MORPHINE in context.
QK-100 “MORPHINE” is in flight test and available for evaluation and demonstrations. Start with the mission, operating environment, and questions your team needs to resolve.
QK-100. Built for the counter-UAS mission.
QK-100 “MORPHINE” / SSX360
QK-100“MORPHINE”
COUNTER-UAS
Available for evaluation
and demonstrations.
Flight tests are underway.
Patent pending
Provisional application filed.
02 / INTELLECTUAL PROPERTY
Patent pending.
A provisional patent application has been filed for QK-100. The public overview is limited to mission, identity, and program status. Technical exchanges require separate review and appropriate arrangements.
Information exchange03 / EVALUATION
Define the operating scope.
Connect the QK-100 deployment pattern to QFN, sensing, OT requirements, and the evidence needed for the decision.
Explore deployment patternsONE AIRCRAFT IDENTITY / QK-100 “MORPHINE”
Deployment follows the mission.
Site and multi-site cells are deployment patterns of the same QK-100 system. The evaluation defines the operating environment and supporting systems for each pattern.
Site cell
Scope QK-100 around a named site, its airspace requirements, interfaces, and evaluation boundaries.
Multi-site cell
Scope the same system across multiple sites, with the relationships and coordination requirements defined together.
WITHIN THE PORTFOLIO
Connect the mission
to the evidence.
QK-100, QFN, and God-Knox define the system discussion. Accountable Evidence Plane connects the evaluation scope to signed records, verification, and decisions.
Define the next step.
Start with general requirements. Further information is subject to review, appropriate agreements, and an agreed transfer channel.
Confidentiality & information exchange